News
Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new ...
WASHINGTON (AP) — Shares of Sarepta Therapeutics plunged Monday after the biotech drugmaker reported a second death in connection with its gene therapy for muscular dystrophy.
“We now have emerging data to at least evaluate the efficacy of gene therapy in patients with a risk of or history of stroke,” Sharma said. “Until now, we only had one option that had a long-term ...
A Northeast Ohio woman and a 22-year-old man from UAE are among the first patients to receive the innovative CRISPR treatment ...
Three-year-old Gunreet Kaur has a rare inherited condition that affects children’s physical, mental and behavioural ...
The Johns Hopkins team that conducted the new study had previously shown that the molecule of interest, an “antisense ...
Elevidys is the first gene therapy approved in the U.S. for the rare muscle-wasting condition, ... Today in History: June 29, Apple releases the first iPhone to consumers ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results